20. CLINICAL, SUBCLINICAL CHARACTERISTICS AND ANTIBIOTIC RESISTANCE OF CO-INFECTING BACTERIA IN CHILDREN WITH RESPIRATORY SYNCYTIAL VIRUS (RSV) PNEUMONIA
Main Article Content
Abstract
Objective: Describe the clinical, subclinical characteristics and antibiotic resistance of bacterial co-infection in children with pneumonia caused by Respiratory Syncytial Virus (RSV) at the Vietnam National Children's Hospital.
Subjects and Methods: A descriptive study conducted on cases of pneumonia due to RSV and bacterial co-infection at the Center for Pulmonology and Respiratory Care, Vietnam National Children's Hospital.
Results: Among the 162 children, 58.6% were male and 41.4% were female. The majority were under 12 months old (68.9%). The most common clinical symptoms were fever (74.7%) and respiratory failure (66.7%). Subclinical tests (X-ray, hematological blood tests, CRP) clearly reflected the level of infection. The prevalence for beta-lactamases producing H. influenzae was high (72,13%) and Haemophilus influenzae showed high resistance to Ampicillin, Cefuroxime, and Cefaclor (>90%). Cefotaxime exhibited a high sensitivity rate (98.2%), and the bacteria were not resistant to Ceftriaxone, Imipenem, and Ciprofloxacin.
Conclusion: Children with RSV pneumonia commonly present with typical clinical signs such as fever, respiratory failure, and lung rales. Subclinical tests indicate significant infection. H. influenzae is the most common co-infected bacteria with a high resistance rate to many antibiotics, requiring caution in choosing antibiotics for treatment.
Article Details
Keywords
Pneumonia, respiratory syncytial virus (RSV), co-bacterial infection, antibiotic resistance, children
References
[2] Y. Li, X. Wang, D. M. Blau, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet, 2022, 399(10340): 2047-2064.
[3] H. Hishiki, N. Ishiwada, C. Fukasawa, et al. Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatients. J Infect Chemother, 2011, 17(1): 87-90.
[4] H. C. Lin, Y. C. Liu, T. Y. Hsing, et al. RSV pneumonia with or without bacterial co-infection among healthy children. J Formos Med Assoc, 2022, 121(3): 687-693.
[5] K. Bohmwald, N. M. S. Gálvez, G. Canedo-Marroquín, et al. Contribution of cytokines to tissue damage during human respiratory syncytial virus infection. Frontiers in Immunology, 2019, 10.
[6] V. G. Nolan, S. R. Arnold, A. M. Bramley, et al. Etiology and impact of co-infections in children hospitalized with community-acquired pneumonia. J Infect Dis, 2018, 218(2): 179-188.
[7] D. Elmore, B. Yaslam, K. Putty, et al. Is fever a red flag for bacterial pneumonia in children with viral bronchiolitis? Glob Pediatr Health, 2019, 6: 2333794x19868660.
[8] S. Esposito, S. Bianchini, M. Gambino et al. Measurement of lipocalin-2 and syndecan-4 levels to differentiate bacterial from viral infection in children with community-acquired pneumonia. BMC Pulm Med, 2016, 16(1): 103.
[9] Trương Thị Việt Nga, Lê Thị Hồng Hanh và Phạm Thu Nga. Tính kháng kháng sinh của vi khuẩn Haemophilus influenze và kết quả điều trị viêm phổi do Haemophilus influenze ở trẻ em tại Bệnh viện Nhi Trung ương. Tạp chí Y học Việt Nam, 2022, 517(2).
[10] M. Zhou, P. Fu, C. Fang, et al. Antimicrobial resistance of Haemophilus influenzae isolates from pediatric hospitals in Mainland China: report from the ISPED program, 2017–2019. Indian J Med Microbiol. 2021, 39(4): 434-438.